GENEDX HOLDINGS CORP (WGS) Stock Fundamental Analysis
USA - NASDAQ:WGS - US81663L2007 - Common Stock
129.79 USD
+0.19 (+0.14%)
129.95 USD
+0.16 (+0.12%)
Taking everything into account, WGS scores 5 out of 10 in our fundamental rating. WGS was compared to 101 industry peers in the Health Care Providers & Services industry. While WGS seems to be doing ok healthwise, there are quite some concerns on its profitability. WGS is valued quite expensively, but it does show have an excellent growth rating.
1. Profitability
1.1 Basic Checks
WGS had positive earnings in the past year.
WGS had a positive operating cash flow in the past year.
WGS had negative earnings in each of the past 5 years.
WGS had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of WGS (0.30%) is comparable to the rest of the industry.
With a Return On Equity value of 0.51%, WGS perfoms like the industry average, outperforming 53.47% of the companies in the same industry.
With a Return On Invested Capital value of 1.09%, WGS perfoms like the industry average, outperforming 42.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.3% | ||
| ROE | 0.51% | ||
| ROIC | 1.09% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
WGS has a Profit Margin (0.39%) which is in line with its industry peers.
WGS has a Operating Margin of 1.50%. This is comparable to the rest of the industry: WGS outperforms 46.53% of its industry peers.
WGS has a better Gross Margin (67.18%) than 86.14% of its industry peers.
In the last couple of years the Gross Margin of WGS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.5% | ||
| PM (TTM) | 0.39% | ||
| GM | 67.18% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
2. Health
2.1 Basic Checks
WGS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
WGS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for WGS has been increased compared to 5 years ago.
The debt/assets ratio for WGS has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 9.08 indicates that WGS is not in any danger for bankruptcy at the moment.
WGS has a Altman-Z score of 9.08. This is amongst the best in the industry. WGS outperforms 93.07% of its industry peers.
The Debt to FCF ratio of WGS is 62.27, which is on the high side as it means it would take WGS, 62.27 years of fcf income to pay off all of its debts.
WGS has a Debt to FCF ratio of 62.27. This is in the lower half of the industry: WGS underperforms 60.40% of its industry peers.
A Debt/Equity ratio of 0.19 indicates that WGS is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.19, WGS is doing good in the industry, outperforming 69.31% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 62.27 | ||
| Altman-Z | 9.08 |
ROIC/WACC0.13
WACC8.75%
2.3 Liquidity
A Current Ratio of 2.87 indicates that WGS has no problem at all paying its short term obligations.
WGS has a Current ratio of 2.87. This is amongst the best in the industry. WGS outperforms 84.16% of its industry peers.
WGS has a Quick Ratio of 2.70. This indicates that WGS is financially healthy and has no problem in meeting its short term obligations.
WGS has a Quick ratio of 2.70. This is amongst the best in the industry. WGS outperforms 84.16% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.87 | ||
| Quick Ratio | 2.7 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 173.71% over the past year.
WGS shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.70%.
Measured over the past years, WGS shows a quite strong growth in Revenue. The Revenue has been growing by 9.26% on average per year.
EPS 1Y (TTM)173.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)48.7%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%45.63%
3.2 Future
Based on estimates for the next years, WGS will show a very strong growth in Earnings Per Share. The EPS will grow by 86.80% on average per year.
WGS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 20.98% yearly.
EPS Next Y579.55%
EPS Next 2Y193%
EPS Next 3Y142.94%
EPS Next 5Y86.8%
Revenue Next Year41.55%
Revenue Next 2Y29.49%
Revenue Next 3Y25.65%
Revenue Next 5Y20.98%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
WGS is valuated quite expensively with a Price/Earnings ratio of 90.76.
WGS's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.41, WGS is valued quite expensively.
With a Price/Forward Earnings ratio of 65.73, WGS can be considered very expensive at the moment.
WGS's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.87, WGS is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.76 | ||
| Fwd PE | 65.73 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, WGS is valued a bit more expensive than 63.37% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of WGS indicates a slightly more expensive valuation: WGS is more expensive than 60.40% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4492.6 | ||
| EV/EBITDA | 124.54 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as WGS's earnings are expected to grow with 142.94% in the coming years.
PEG (NY)0.16
PEG (5Y)N/A
EPS Next 2Y193%
EPS Next 3Y142.94%
5. Dividend
5.1 Amount
No dividends for WGS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
129.79
+0.19 (+0.14%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.48%
Inst Owner Change9.85%
Ins Owners1.59%
Ins Owner Change0.62%
Market Cap3.73B
Analysts83.64
Price Target126.23 (-2.74%)
Short Float %14.43%
Short Ratio4.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)375.13%
Min EPS beat(2)364.92%
Max EPS beat(2)385.34%
EPS beat(4)4
Avg EPS beat(4)286.61%
Min EPS beat(4)118.42%
Max EPS beat(4)385.34%
EPS beat(8)8
Avg EPS beat(8)163.97%
EPS beat(12)9
Avg EPS beat(12)102.26%
EPS beat(16)11
Avg EPS beat(16)69.88%
Revenue beat(2)2
Avg Revenue beat(2)12.92%
Min Revenue beat(2)6.85%
Max Revenue beat(2)18.99%
Revenue beat(4)4
Avg Revenue beat(4)14.53%
Min Revenue beat(4)6.85%
Max Revenue beat(4)18.99%
Revenue beat(8)8
Avg Revenue beat(8)12.68%
Revenue beat(12)11
Avg Revenue beat(12)9.63%
Revenue beat(16)14
Avg Revenue beat(16)5.31%
PT rev (1m)7.34%
PT rev (3m)30.26%
EPS NQ rev (1m)10.92%
EPS NQ rev (3m)50.78%
EPS NY rev (1m)0%
EPS NY rev (3m)45.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)11.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 90.76 | ||
| Fwd PE | 65.73 | ||
| P/S | 10.29 | ||
| P/FCF | 4492.6 | ||
| P/OCF | 286.31 | ||
| P/B | 13.46 | ||
| P/tB | 42.61 | ||
| EV/EBITDA | 124.54 |
EPS(TTM)1.43
EY1.1%
EPS(NY)1.97
Fwd EY1.52%
FCF(TTM)0.03
FCFY0.02%
OCF(TTM)0.45
OCFY0.35%
SpS12.61
BVpS9.65
TBVpS3.05
PEG (NY)0.16
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.3% | ||
| ROE | 0.51% | ||
| ROCE | 1.38% | ||
| ROIC | 1.09% | ||
| ROICexc | 1.66% | ||
| ROICexgc | 6.29% | ||
| OM | 1.5% | ||
| PM (TTM) | 0.39% | ||
| GM | 67.18% | ||
| FCFM | 0.23% |
ROA(3y)-55.43%
ROA(5y)-61.29%
ROE(3y)-104.93%
ROE(5y)-1172.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y10.27%
F-Score8
Asset Turnover0.78
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 62.27 | ||
| Debt/EBITDA | 1.8 | ||
| Cap/Depr | 52.21% | ||
| Cap/Sales | 3.37% | ||
| Interest Coverage | 0.93 | ||
| Cash Conversion | 45.24% | ||
| Profit Quality | 59.03% | ||
| Current Ratio | 2.87 | ||
| Quick Ratio | 2.7 | ||
| Altman-Z | 9.08 |
F-Score8
WACC8.75%
ROIC/WACC0.13
Cap/Depr(3y)22.03%
Cap/Depr(5y)86.79%
Cap/Sales(3y)3.57%
Cap/Sales(5y)7.67%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)173.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next Y579.55%
EPS Next 2Y193%
EPS Next 3Y142.94%
EPS Next 5Y86.8%
Revenue 1Y (TTM)48.7%
Revenue growth 3Y12.91%
Revenue growth 5Y9.26%
Sales Q2Q%45.63%
Revenue Next Year41.55%
Revenue Next 2Y29.49%
Revenue Next 3Y25.65%
Revenue Next 5Y20.98%
EBIT growth 1Y106.43%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year586.36%
EBIT Next 3Y145.14%
EBIT Next 5YN/A
FCF growth 1Y100.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y104.97%
OCF growth 3YN/A
OCF growth 5YN/A